ZYDUS LIFESCIENCES LIMITED IR

press release

Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis - 29/08/2025

Source document

Issuer site

Loading document…

Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis - 29/08/2025 — ZYDUS LIFESCIENCES LIMITED